Clinical Report: The Dialogue Between Host and Microbiota in Immunometabolism
Overview
This editorial discusses the complex interactions between host physiology and microbiota, emphasizing their role in immune homeostasis and disease susceptibility. It highlights microbial metabolites in systemic signaling.
Background
The relationship between host and microbiota is crucial for understanding immune regulation and disease mechanisms. Microbial signals can influence distant tissues, affecting immune responses and overall health.
Data Highlights
No numerical data presented in the article.
Key Findings
Microbiota composition primarily facilitates communication through metabolic pathways rather than directly impacting physiology.
Ricci et al. identified microbiota-derived metabolites as systemic signaling molecules in MS patients, particularly noting changes in indole levels.
He et al. mapped the distribution of SCFA receptors, highlighting their role in inflammation and tissue recovery.
Ye et al. discussed the bidirectional relationship between pneumonia and gut dysbiosis, mediated by SCFAs.
Qi et al. described how gut microbiota metabolites contribute to gout pathogenesis and inflammation.
Wei et al. demonstrated that microbiota transplantation can restore immune function and improve metabolic outcomes in hyperlipidemic patients.
Clinical Implications
Understanding the host-microbiota dialogue can inform therapeutic strategies targeting metabolic and inflammatory diseases.
Conclusion
The editorial presents new avenues for research and clinical application regarding the host-microbiota interaction in immunometabolism.
